|
Vice President, Head of Business Development, Transactions
|
Cambridge, MA, US, 02142
|
May 13, 2026
|
Full-Time
|
|
|
Délégué Hospitalier en cardiologie et neurologie - région Paris & Normandie
|
FR
|
May 14, 2026
|
Full-Time
|
|
|
Sr. Manager, Salesforce Developer
|
Cambridge, MA, US, 02142
|
May 14, 2026
|
Full-Time
|
|
|
Délégué Hospitalier en cardiologie et neurologie, Sud Est - région PACA
|
FR
|
May 14, 2026
|
Full-Time
|
|
|
Scientist, Process Sciences
|
Cambridge, MA, US, 02142
|
May 14, 2026
|
Full-Time
|
|
|
Associate Director, Field Business Lead - Rare Diseases
|
CA
|
May 14, 2026
|
Full-Time
|
|
|
Sr Manager, Medical Writing
|
Maidenhead, GB, SL6 1DA
|
May 14, 2026
|
Full-Time
|
|
|
Associate Director, Business Development, Transactions
|
Cambridge, MA, US, 02142
|
May 15, 2026
|
Full-Time
|
|
|
Senior Clinical Data Manager
|
GB
|
May 15, 2026
|
Full-Time
|
|
|
Business Account Executive, TTR - Peoria, IL
|
Cambridge, MA, US, 02142
|
May 15, 2026
|
Full-Time
|
|
|
Senior Director, Research & Early Development Technology
|
Cambridge, MA, US, 02142
|
May 15, 2026
|
Full-Time
|
|
|
Director, New Product Planning & BD Support
|
Cambridge, MA, US, 02142
|
May 15, 2026
|
Full-Time
|
|
|
Associate Director, Medical Communications and Publications
|
Cambridge, MA, US, 02142
|
May 15, 2026
|
Full-Time
|
|
|
Senior Medical Director, US Medical Affairs - TTR
|
Cambridge, MA, US, 02142
|
May 15, 2026
|
Full-Time
|
|
|
Director, Global New Product Commercialization, Metabolic
|
Cambridge, MA, US, 02142
|
May 16, 2026
|
Full-Time
|
|
|
Vice President, Pipeline Delivery Systems & Process Enablement
|
Cambridge, MA, US, 02142
|
May 16, 2026
|
Full-Time
|
|
|
Vice President, Global Trial Optimization
|
Cambridge, MA, US, 02142
|
May 16, 2026
|
Full-Time
|
|
|
Manager, Manufacturing Operations
|
Norton, MA, US, 02766
|
May 16, 2026
|
Full-Time
|
|
|
Senior Manager, Quality Assurance (PVQA)
|
Maidenhead, GB, SL6 1DA
|
May 16, 2026
|
Full-Time
|
|
|
Sr Director, Global Market Insights
|
Cambridge, MA, US, 02142
|
May 17, 2026
|
Full-Time
|
|